HELX

Franklin Genomic Advancements ETF

HELX | CBOE
$45.25
-$0.76 (-1.65%)
At close: Oct 30, 2026, 3:59 PM ET
-1.65%

No price chart data available for 1D timeframe.

Key Statistics

Market Cap 36.2M
AVG Volume 5.45K
AUM 36.21M
NAV 45.26
1D Range
44.81 46.24
52W Range
31.24 46.24

About HELX

This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as tho...

Asset Class Equity
Holdings 63
Inception Date Feb 25, 2020
Expense Ratio 0.5%
Domicile United States
ISIN US35473P5200

Top Sectors

Sector Weight
Healthcare 97.04%
Basic Materials 2.28%
Technology 0.68%

Top Holdings

33.48% of assets
Name Symbol Weight
Natera Inc NTRA 10.04%
Guardant Health Inc GH 9.55%
Krystal Biotech Inc KRYS 4.99%
Ligand Pharmaceutica... LGND 4.53%
Adaptive Biotechnolo... ADPT 4.37%

Dividends

Yield 0.32%
Ex-Div Amount Pay Date
Dec 30, 25 $0.1433 Jan 8, 26
Dec 30, 21 $0.0039 Jan 7, 22
Dec 13, 21 $0.1142 Dec 21, 21
Dec 14, 20 $0.0518 Dec 23, 20

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.